Aradigm Announces Submission of Responses to EMA Day 120 Questions and Meeting with FDA - Business Wire

Aradigm Announces Submission of Responses to EMA Day 120 Questions and Meeting with FDA  Business Wire

Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) submitted responses to the European Medicines Agency (EMA) Day 120 questions on 23 ...



Comments

Popular posts from this blog

Mpox - Vancouver